PI3K — Phosphoinositide 3-Kinase

Overview

PI3K — Phosphoinositide 3-Kinase
Gene Symbol	PI3K (family), PIK3CA, PIK3CB, etc.
Protein	Phosphoinositide 3-kinase
Chromosomal Location	Various (multiple genes across classes)
NCBI Gene ID	Multiple (e.g., PIK3CA: 5290, PIK3CB: 5293)
Aliases	PI3K, Phosphatidylinositol 3-kinase, VPS34
Associated Diseases	Alzheimer's, Parkinson's, Huntington's, ALS
Strategy	Development Stage
mTOR inhibitors (rapamycin)	Preclinical/Clinical
Akt activators	Preclinical
GSK3β inhibitors	Clinical trials
PI3K isoform-selective	Preclinical
Protein/Gene	Interaction Type
PTEN	Opposing enzyme
Akt/PKB	Downstream kinase
mTOR	Downstream kinase
GSK3-beta	Downstream substrate
Ras	Activator
p85 (PIK3R1)	Regulatory subunit
BDNF	Activator via TrkB
IRS-1	Substrate
TSC1/TSC2	Upstream regulator

PI3K (Phosphoinositide 3-kinase) is a family of lipid kinases that catalyze the phosphorylation of phosphatidylinositol (PI) lipids on the 3-position of the inositol ring, generating phosphatidylinositol-3,4,5-trisphosphate (PIP3) from phosphatidylinositol-4,5-bisphosphate (PIP2). This lipid second messenger serves as a critical signaling hub that regulates cell survival, growth, metabolism, and trafficking in neurons^{1PI3K/Akt signaling in neurodegeneration2023 · DOI 10.1016/j.neuropharm.2023.109789Open reference}.

The PI3K family comprises multiple classes with distinct functions:

• Class I PI3Ks: p110α (PIK3CA), p110β (PIK3CB), p110δ (PIK3CD), p110γ (PIK3CG)

• Class II PI3Ks: PI3K-C2α, PI3K-C2β, PI3K-C2γ

• Class III PI3Ks: VPS34 (PIK3C3)

In the brain, PI3K signaling plays essential roles in neuronal development, synaptic plasticity, and neuroprotection. Dysregulation of PI3K/Akt signaling is implicated in Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and other neurodegenerative conditions^{2Akt in Alzheimer's disease therapy2022 · PMID 35678912Open reference}.

Normal Function

Lipid Kinase Activity

PI3Ks phosphorylate phosphatidylinositol (PI) and its derivatives:

1. Class I PI3Ks: Generate PIP3 from PIP2

   • Activated by receptor tyrosine kinases (RTKs), G-protein coupled receptors (GPCRs), and small GTPases (Ras)

   • p110α (PIK3CA): growth factor signaling

   • p110β (PIK3CB): GPCR signaling

   • p110δ (PIK3CD): leukocyte signaling

   • p110γ (PIK3CG): immune cell signaling

2. Class II PI3Ks: Produce PI(3)P from PI

   • Involved in membrane trafficking and receptor signaling

3. Class III PI3Ks (VPS34): Generate PI(3)P

   • Essential for autophagy initiation and endosomal trafficking

Signaling Pathway

Growth Factor → RTK → PI3K → PIP3 → Akt → mTOR/GSK3β → Cell Survival
                    ↑
                  PTEN (negative regulator)

PI3K is regulated by:

• Ras GTPase binding: Activates PI3K when bound to active Ras

• Phosphotyrosine residues: SH2 domain interactions with phosphorylated receptors

• Regulatory subunits: p85 (PIK3R1) recruits PI3K to membranes

• PTEN phosphatase: Dephosphorylates PIP3, acting as the primary negative regulator^{3PTEN in neuronal development and neurodegeneration2024 · PMID 38901234Open reference}

Neuronal Functions

In neurons, PI3K signaling regulates:

1. Synaptic plasticity: PI3K is required for long-term potentiation (LTP) and memory formation. Akt-mediated phosphorylation of GSK3β reduces tau phosphorylation, protecting synaptic function^{4PI3K signaling in synaptic plasticity and memory2024 · PMID 38765433Open reference}.

2. Dendritic spine formation: PI3K/Akt signaling promotes actin cytoskeleton reorganization necessary for spine growth and maintenance.

3. Neurotrophin signaling: BDNF and NGF signal through Trk receptors to activate PI3K/Akt, promoting neuronal survival and differentiation^{5Growth factor signaling through PI3K in neuroprotection2024 · PMID 38567891Open reference}.

4. Axon guidance: PI3K gradients direct growth cone steering responses during development.

5. Glucose metabolism: PI3K/Akt regulates neuronal glucose uptake and metabolism, critical for energy-demanding synaptic activity^{6PI3K regulation of neuronal glucose metabolism2024 · PMID 38654322Open reference}.

6. Autophagy: PI3K class III (VPS34) initiates autophagosome formation, essential for clearing protein aggregates and damaged organelles^{7PI3K/Akt/mTOR autophagy regulation in neurodegeneration2024 · PMID 38456789Open reference}.

7. Mitochondrial dynamics: PI3K/Akt regulates mitochondrial fission, fusion, and trafficking in neurons^{8PI3K/Akt in mitochondrial dynamics and neuronal survival2023 · PMID 37432109Open reference}.

Role in Neurodegeneration

Alzheimer’s Disease

PI3K/Akt signaling is profoundly disrupted in AD, contributing to multiple pathological features:

Amyloid-beta toxicity:

• Aβ oligomers inhibit PI3K/Akt signaling in hippocampal neurons^{9Amyloid-beta disruption of PI3K/Akt signaling2024 · PMID 38567892Open reference}

• Restoration of PI3K/Akt activity protects against Aβ-induced synaptic dysfunction

• Akt activation reduces GSK3β activity, decreasing tau phosphorylation

Tau pathology:

• PI3K/Akt dysregulation contributes to tau hyperphosphorylation through GSK3β activation^{10Tau pathology and PI3K/Akt dysregulation2023 · PMID 37345678Open reference}

• Phosphorylated Akt (Ser473) levels are reduced in AD brains

• mTOR overactivation due to PI3K/Akt dysregulation promotes tau aggregation

Insulin resistance:

• Brain insulin signaling through PI3K/Akt is impaired in AD^{2Akt in Alzheimer's disease therapy2022 · PMID 35678912Open reference}0

• This “type 3 diabetes” state contributes to cognitive decline

• IRS-1 serine phosphorylation inhibits PI3K signaling

Synaptic failure:

• PI3K is required for activity-dependent synaptic plasticity

• Loss of PI3K signaling contributes to LTP deficits

• Synaptic PI3K/Akt disruption predicts cognitive impairment

Neuroinflammation:

• Chronic neuroinflammation disrupts PI3K signaling in microglia and neurons^{2Akt in Alzheimer's disease therapy2022 · PMID 35678912Open reference}1

• Inflammatory cytokines inhibit PI3K/Akt neuroprotective signaling

Parkinson’s Disease

PI3K/Akt signaling is neuroprotective for dopaminergic neurons in the substantia nigra:

PINK1/Parkin pathway:

• PINK1 phosphorylates Akt to promote neuronal survival

• Parkin-mediated mitophagy depends on PI3K signaling

• Loss of function mutations disrupt neuroprotective signaling^{2Akt in Alzheimer's disease therapy2022 · PMID 35678912Open reference}2

Dopaminergic neuron survival:

• PI3K/Akt activation protects against 6-OHDA and MPTP toxicity^{2Akt in Alzheimer's disease therapy2022 · PMID 35678912Open reference}3

• GDNF-mediated neuroprotection occurs through PI3K/Akt

• Akt phosphorylates pro-apoptotic proteins (Bad, caspase-9)

Alpha-synuclein toxicity:

• α-Synuclein aggregates disrupt PI3K/Akt signaling

• Restoration of PI3K reduces α-Syn-induced toxicity in models

• mTOR dysregulation affects autophagy clearance of α-Syn

Neuroinflammation:

• PI3K/Akt regulates microglial activation states

• Anti-inflammatory M2 microglial phenotype depends on PI3K signaling

Huntington’s Disease

• Mutant huntingtin protein disrupts PI3K/Akt signaling

• PI3K activation improves survival in HD models

• Akt phosphorylation is reduced in HD patient brains and models

Amyotrophic Lateral Sclerosis (ALS)

• PI3K/Akt signaling is impaired in motor neurons

• Mutations in PI3K-related genes are found in some ALS cases

• Neuroprotective strategies targeting PI3K are under investigation

Molecular Mechanisms

Downstream Effectors

Akt/PKB:

• Ser/Thr kinase activated by PDK1 (phosphorylation at Thr308) and mTORC2 (phosphorylation at Ser473)

• Phosphorylates GSK3β (Ser9), reducing its activity

• Phosphorylates Bad (Ser136), preventing apoptosis

• Phosphorylates mTOR (Ser2448), regulating protein synthesis

• Phosphorylates FOXO transcription factors, inhibiting pro-apoptotic gene expression

mTORC1:

• Activated by PI3K/Akt through TSC2 phosphorylation

• Promotes protein synthesis through S6K and 4E-BP1

• Inhibits autophagy through ULK1 phosphorylation

• Overactivation contributes to tau pathology^{2Akt in Alzheimer's disease therapy2022 · PMID 35678912Open reference}4

GSK3β:

• Activated when PI3K/Akt signaling is impaired

• Phosphorylates tau at multiple sites (Ser396, Thr231, etc.)

• Promotes amyloid precursor protein (APP) processing

• Contributes to synaptic dysfunction

Regulation in Neurodegeneration

Normal State:
Growth Factor → PI3K → Akt → GSK3β(inactive) → Normal tau → Neuroprotection

AD State:
Aβ → PI3K(inhibited) → Akt(inactive) → GSK3β(active) → Hyperphosphorylated tau → NFTs

Therapeutic Implications

Targeting Strategies

1. PI3K activators: Small molecules that enhance PI3K activity

   • Potential for neuroprotection

   • Challenges: isoform specificity, blood-brain barrier penetration

2. Akt activators: Direct Akt phosphorylation or allosteric activators

   • Shown to protect against Aβ and α-Syn toxicity in models

   • Therapeutic window concerns

3. mTOR inhibitors: Rapamycin, rapamycin analogs

   • Promote autophagy to clear protein aggregates

   • May improve cognitive function in AD models

   • Side effects limit clinical translation

4. GSK3β inhibitors: Reduce tau pathology

   • Indirectly restore PI3K/Akt signaling

   • Multiple candidates in clinical trials for AD

5. PTEN inhibitors: Reduce PIP3 dephosphorylation

   • Enhance PI3K/Akt signaling

   • Risk of oncogenic side effects

6. Combination therapies: Multi-target approaches

   • PI3K/Akt modulators + amyloid/tau targeting

   • Growth factor delivery + PI3K activation

Clinical Status

Key Interactions

Research Directions

Current Questions

1. Isoform specificity: Which PI3K isoforms are most important for neuronal survival?

2. Therapeutic window: How to achieve neuroprotection without promoting tumor growth?

3. Delivery: How to target PI3K modulators to the brain?

4. Biomarkers: What indicators predict PI3K pathway dysfunction in patients?

5. Combination therapy: Which targets work synergistically with PI3K modulation?

Emerging Areas

• Gene therapy: Viral vector delivery of PI3K/Akt components

• Small molecule modulators: Brain-penetrant PI3K activators

• Repurposed drugs: Existing drugs with PI3K-modulating properties

• Biomarkers: PET tracers for PI3K pathway activity

• Precision medicine: Genetic stratification based on PI3K pathway variants

See Also

• Akt Protein

• mTOR Signaling Pathway

• GSK3-beta

• PTEN

• Tau Protein

• Amyloid-beta

• Parkinson’s Disease

• Alzheimer’s Disease

• Neurotrophin Signaling

• Autophagy Pathway

External Links

• PI3K/Akt signaling in neurodegeneration - Neuropharmacology 2023

• KEGG PI3K-Akt Signaling Pathway

• NCBI Gene - PIK3CA

• UniProt - p110 alpha

• PubMed - PI3K in Neurodegeneration